Sofosbuvir CAS 1190307-88-0 Puritas ≥99.0% (HPLC)
| Nomen | Sofosbuvir |
| Synonyma | GS-7977;PSI-7977 |
| CAS Number | 1190307-88-0 |
| Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
| Formulae hypotheticae | C22H29FN3O9P |
| M. Pondus | 529.45 |
| Liquescens punctum | 120.0~ 125.0℃ |
| Density | 1.41 |
| Solubilitas | Solutum in DMF, DMSO, Ethanol |
| Shipping Condition | Sub Ambient Temperature |
| COA & MSDS | Praesto |
| Origin | Shanghai, China |
| Fasciae vita | XXXVI Menses si Repono Proprie |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White Crystalline pulveris |
| Lepidium sativum | HPLC;RT |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| EE | ≥99.0% |
| Damnum in Siccatio | ≤1.0% |
| Residere in Ignition | ≤0.20% |
| una immunditia | ≤0.50% |
| Totalis immunditias | ≤1.0% |
| Metalla gravis | ≤20ppm |
| RELICTUM Solvents | Cum requisitis specifications |
| Methanol | ≤1500ppm |
| TBME | ≤2500ppm |
| Dichloromethane | ≤720ppm |
| Tetrahydrofuran | ≤720ppm |
| Toluene | ≤60ppm |
| Test Standard | Enterprise Standard |
| Consuetudinem | Sofosbuvir (CAS: 1190307-88-0) in curatione Hepatitis C Viris (HCV) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore
Sofosbuvir (CAS: 1190307-88-0) (formaliter intitulatum ut PSI-797, GS-7977) est phosphoramidata prodrug et polymerasis nucleotide inhibitor ad curationem infectio viri longi hepatitis C (HCV).Commendatur utendum in compositione cum aliis medicamentis (ut velpatasvir) pro genotypes HCV primae lineae curationis 1, 2, 3, 4, 5, et 6. Effectum obtinet per modum agentis inhibitoris nucleotidis analogi, ex. RNA-dependens RNA polymerasis RNA dependens.
Epistulam tuam hic scribe et mitte nobis